Udompatanakorn
C, Patcharaman S, Taebunpakul P. The expression of Methyltransferase-like 3 in
dentigerous cyst and ameloblastoma. J Clin Exp Dent. 2024;16(12):e1481-8.
doi:10.4317/jced.62186
https://doi.org/10.4317/jced.62186
_____
References
|
1.
Bhat A, Mitra S, Chandrashekar C, Solomon M, Kulkarni S. Odontogenic cysts
and odontogenic tumors in a large rural area from India. A 10-year
reflection. Med Pharm Rep. 2019;92(4):408-12. |
|
|
|
|
|
2.
Nahajowski M, Hnitecka S, Antoszewska-Smith J, Rumin K, Dubowik M, Sarul M.
Factors influencing an eruption of teeth associated with a dentigerous cyst:
a systematic review and meta-analysis. BMC Oral Health. 2021;21(1):180. |
|
|
|
|
|
3.
Bhushan NS, Rao NM, Navatha M, Kumar BK. Ameloblastoma arising from a
dentigerous cyst-a case report. J Clin Diagn Res. 2014;8(5):ZD23-5. PMid:24995259
PMCid:PMC4080080 |
|
|
|
|
|
4.
Effiom OA, Ogundana OM, Akinshipo AO, Akintoye SO. Ameloblastoma: current
etiopathological concepts and management. Oral Dis. 2018;24(3):307-16. |
|
|
|
|
|
5.
Hamza M, Kim J, Badash I, Kokot N. Ameloblastoma of the Mandible With
Carcinoma Transformation in a Young Adult. Ear Nose Throat J.
2023:1455613231172857. |
|
|
|
|
|
6.
Soluk-Tekkesin M, Wright JM. The World Health Organization Classification of
Odontogenic Lesions: A Summary of the Changes of the 2022 (5th) Edition. Turk
Patoloji Derg. 2022;38(2):168-84. |
|
|
|
|
|
7.
An Y, Duan H. The role of m6A RNA methylation in cancer metabolism. Mol
Cancer. 2022;21(1):14. |
|
|
|
|
|
8.
Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, et al. The role of m6A
modification in the biological functions and diseases. Signal Transduct
Target Ther. 2021;6(1):74. |
|
|
|
|
|
9.
Zeng C, Huang W, Li Y, Weng H. Roles of METTL3 in cancer: mechanisms and
therapeutic targeting. J Hematol Oncol. 2020;13(1):117. |
|
|
|
|
|
10.
Zhai Y, Zheng L. m6A RNA methylation regulator-related signatures exhibit
good prognosis prediction ability for head and neck squamous cell carcinoma.
Sci Rep. 2022;12(1):16358. |
|
|
|
|
|
11.
Udompatanakorn C, Taebunpakul P. The Expression of Methyltransferase-Like 3
in Oral Precancerous Lesions and Oral Squamous Cell Carcinoma. Eur J Dent.
2023;17(2):349-56. |
|
|
|
|
|
12.
Wu S, Makeudom A, Sun X, Li X, Xu D, Sastraruji T, et al. Overexpression of
methyltransferase-like 3 and 14 in oral squamous cell carcinoma. J Oral
Pathol Med. 2022;51(2):134-45. |
|
|
|
|
|
13.
Xu L, Li Q, Wang Y, Wang L, Guo Y, Yang R, et al. m(6)A methyltransferase
METTL3 promotes oral squamous cell carcinoma progression through enhancement
of IGF2BP2-mediated SLC7A11 mRNA stability. Am J Cancer Res.
2021;11(11):5282-98. PMid:34873461
PMCid:PMC8640804 |
|
|
|
|
|
14.
Guimaraes LM, Coura BP, Gomez RS, Gomes CC. The Molecular Pathology of
Odontogenic Tumors: Expanding the Spectrum of MAPK Pathway Driven Tumors.
Front Oral Health. 2021;2:740788. |
|
|
|
|
|
15.
Vered M, Wright JM. Update from the 5th Edition of the World Health
Organization Classification of Head and Neck Tumors: Odontogenic and
Maxillofacial Bone Tumours. Head Neck Pathol. 2022;16(1):63-75. |
|
|
|
|
|
16.
Han J, Wang JZ, Yang X, Yu H, Zhou R, Lu HC, et al. METTL3 promote tumor
proliferation of bladder cancer by accelerating pri-miR221/222 maturation in
m6A-dependent manner. Mol Cancer. 2019;18(1):110. |
|
|
|
|
|
17.
Fedchenko N, Reifenrath J. Different approaches for interpretation and
reporting of immunohistochemistry analysis results in the bone tissue - a
review. Diagn Pathol. 2014;9:221. |
|
|
|
|
|
18.
Chen X, Huang L, Yang T, Xu J, Zhang C, Deng Z, et al. METTL3 Promotes
Esophageal Squamous Cell Carcinoma Metastasis Through Enhancing GLS2
Expression. Front Oncol. 2021;11:667451. |
|
|
|
|
|
19.
Guo YQ, Wang Q, Wang JG, Gu YJ, Song PP, Wang SY, et al. METTL3 modulates m6A
modification of CDC25B and promotes head and neck squamous cell carcinoma
malignant progression. Exp Hematol Oncol. 2022;11(1):14. |
|
|
|
|
|
20.
Lin C, Li T, Wang Y, Lai S, Huang Y, Guo Z, et al. METTL3 enhances pancreatic
ductal adenocarcinoma progression and gemcitabine resistance through
modifying DDX23 mRNA N6 adenosine methylation. Cell Death Dis.
2023;14(3):221. |
|
|
|
|
|
21.
Pan Y, Chen H, Zhang X, Liu W, Ding Y, Huang D, et al. METTL3 drives
NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting
immunotherapy. Cell Rep Med. 2023;4(8):101144. |
|
|
|
|
|
22.
Gadbail AR, Patil R, Chaudhary M. Co-expression of Ki-67 and p53 protein in
ameloblastoma and keratocystic odontogenic tumor. Acta Odontol Scand.
2012;70(6):529-35. |
|
|
|
|
|
23.
Sang L, Wu X, Yan T, Naren D, Liu X, Zheng X, et al. The m(6)A RNA
methyltransferase METTL3/METTL14 promotes leukemogenesis through the mdm2/p53
pathway in acute myeloid leukemia. J Cancer. 2022;13(3):1019-30. |
|
|
|
|
|
24.
Moreira PR, Guimaraes MM, Gomes CC, Diniz MG, Brito JA, de Castro WH, et al.
Methylation frequencies of cell-cycle associated genes in epithelial
odontogenic tumours. Arch Oral Biol. 2009;54(10):893-7. |
|
|
|
|
|
25.
Zhang Y, Liu S, Zhao T, Dang C. METTL3‑mediated m6A modification of Bcl‑2
mRNA promotes non‑small cell lung cancer progression. Oncol Rep. 2021;46(2). |
|
|
|
|
|
26.
Razavi SM, Torabinia N, Mohajeri MR, Shahriyary S, Ghalegolab S, Nouri S.
Expression of Bcl-2 and epithelial growth factor receptor proteins in
keratocystic odontogenic tumor in comparison with dentigerous cyst and
ameloblastoma. Dent Res J (Isfahan). 2015;12(4):342-7. |
|
|
|
|
|
27.
Escobar E, Gomez-Valenzuela F, Penafiel C, Chimenos-Kustner E, Perez-Tomas R.
Aberrant immunoexpression of p53 tumour-suppressor and Bcl-2 family proteins
(Bcl-2 and Bax) in ameloblastomas and odontogenic keratocysts. J Clin Exp
Dent. 2023;15(2):e125-e34. PMid:36911151
PMCid:PMC9994657 |
|
|
|
|
|
28.
Bhattarai PY, Kim G, Poudel M, Lim SC, Choi HS. METTL3 induces PLX4032
resistance in melanoma by promoting m(6)A-dependent EGFR translation. Cancer
Lett. 2021;522:44-56. |
|
|
|
|
|
29.
Kochaji N, Barbar R, Al-Assaf M, Barakat C. Extremely rare maxillary
unicystic ameloblastoma causing double vision: First case report in the
Middle East. Int J Surg Case Rep. 2023;109:108485. |
|